Grey matter changes associated with heavy cannabis use: A longitudinal sMRI study

PLoS ONE

Volumn 11, Issue 5, 2016, Pages

  Koenders, Laura ^a   Cousijn, Janna ^a,c   Vingerhoets, Wilhelmina A M ^a,b   Van Den Brink, Wim ^a   Wiers, Reinout W ^a   Meijer, Carin J ^a   Machielsen, Marise W J ^a   Veltman, Dick J ^e   Goudriaan, Anneke E ^a,d   De Haan, Lieuwe ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c UTRECHT UNIVERSITY   (Netherlands)

^d Arkin Mental Health Amsterdam   (Netherlands)

^e VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENCE; ADOLESCENT; ADULT; ADULTHOOD; AMYGDALA; ANTERIOR CINGULATE; ARTICLE; BRAIN SIZE; CANNABIS ADDICTION; CANNABIS USE; CEREBELLUM; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; CROSS-SECTIONAL STUDY; DRINKING BEHAVIOR; FEMALE; FOLLOW UP; GRAY MATTER; HIPPOCAMPUS; HUMAN; INSULA; LONG TERM EXPOSURE; LONGITUDINAL STUDY; MALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; ORBITAL CORTEX; PSYCHOLOGIC ASSESSMENT; RISK FACTOR; THALAMUS; DIAGNOSTIC IMAGING; YOUNG ADULT;

CANNABIS;

ADULT; CANNABIS; FEMALE; GRAY MATTER; HUMANS; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; MARIJUANA ABUSE; YOUNG ADULT;

EID: 84971413390     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0152482     Document Type: Article

References (51)

1. Degenhardt L, Hall W (2012): Extent of illicit drug use and dependence, and their contribution to the global burden of disease. The Lancet 379:55-70.
2. Wittchen H, Fröhlich C, Behrendt S, Günther A, Rehm J, Zimmermann P, et al (2007): Cannabis use and cannabis use disorders and their relationship to mental disorders: A 10-year prospective-longitudinal community study in adolescents. Drug Alcohol Depend 88, Supplement 1:S60-S70.
3. Copeland J, Rooke S, Swift W (2013): Changes in cannabis use among young people: impact on mental health. Current Opinion in Psychiatry 26:325-329. doi: 10.1097/YCO.0b013e328361eae5 PMID: 23689549
4. Scholes-Balog KE, Hemphill SA, Patton GC, Toumbourou JW (2013): Cannabis use and related harms in the transition to young adulthood: A longitudinal study of Australian secondary school students. J Adolesc 36:519-527. doi: 10.1016/j.adolescence.2013.03.001 PMID: 23522345
5. Arseneault L, Cannon M, Poulton R, Murray R, Caspi A, Terrie EM (2002): Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. BMJ 325:.
6. Hall WD (2006): Cannabis use and the mental health of young people. Aust NZ J Psychiatry 40:105-113.
7. Moore TH, Zammit S, Lingford-Hughes A, Barnes TR, Jones PB, Burke M, et al (2007): Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. The Lancet 370:319-328.
8. van Os J, Bak M, Hanssen M, Bijl RV, de Graaf R, Verdoux H (2002): Cannabis Use and Psychosis: A Longitudinal Population-based Study. American Journal of Epidemiology 156:319-327. PMID: 12181101
9. Meier MH, Caspi A, Ambler A, Harrington H, Houts R, Keefe RSE, et al (2012): Persistent cannabis users show neuropsychological decline from childhood to midlife. Proceedings of the National Academy of Sciences 109:E2657-E2664.
10. Lorenzetti V, Lubman DI, Whittle S, Solowij N, Yücel M (2010): Structural MRI Findings in Long-Term Cannabis Users: What Do We Know? Subst Use Misuse 45:1787-1808. doi: 10.3109/10826084.2010.482443 PMID: 20590400
11. Lorenzetti V, Solowij N, Fornito A, Lubman DI, Yücel M (2013): The Association between Regular Cannabis Exposure and Alterations of Human Brain Morphology: An Updated Review of the Literature. Curr Pharm Des 20:.
12. Matochik JA, Eldreth DA, Cadet J, Bolla KI (2005): Altered brain tissue composition in heavy marijuana users. Drug Alcohol Depend 77:23-30. PMID: 15607838
13. Yücel M, Solowij N, Respondek C, Whittle S, Fornito A, Pantelis C, et al (2008): Regional brain abnormalities associated with long-term heavy cannabis use. Archives of General Psychiatry 65:694-701. doi: 10.1001/archpsyc.65.6.694 PMID: 18519827
14. Tzilos GK, Cintron CB, Wood JBR, Simpson NS, Young AD, Pope HG, et al (2005): Lack of Hippocampal Volume Change in Long-term Heavy Cannabis Users. American Journal on Addictions 14:64-72. PMID: 15804878
15. Block RI, O'Leary DS, Ehrhardt JC, Augustinack JC, Ghoneim MM, Arndt S, et al (2000): Effects of frequent marijuana use on brain tissue volume and composition. Neuroreport 11:491-496. PMID: 10718301
16. Jager G, Van Hell HH, De Win MML, Kahn RS, Van Den Brink W, Van Ree JM, et al (2007): Effects of frequent cannabis use on hippocampal activity during an associative memory task. European Neuropsychopharmacology 17:289-297. PMID: 17137758
17. Cousijn J, Wiers RW, Ridderinkhof KR, van den Brink W, Veltman DJ, Goudriaan AE (2012): Grey matter alterations associated with cannabis use: Results of a VBM study in heavy cannabis users and healthy controls. Neuroimage 59:3845-3851. doi: 10.1016/j.neuroimage.2011.09.046 PMID: 21982932
18. Medina KL, McQueeny T, Nagel BJ, Hanson KL, Yang TT, Tapert SF (2009): Prefrontal cortex morphometry in abstinent adolescent marijuana users: subtle gender effects. Addict Biol 14:457-468. doi: 10.1111/j.1369-1600.2009.00166.x PMID: 19650817
19. DeLisi LE, Bertisch HC, Szulc KU, Majcher M, Brown K, Bappal A, et al (2006): A preliminary DTI study showing no brain structural change associated with adolescent cannabis use. Harm Reduction Journal 3:1-6.
20. Weiland BJ, Thayer RE, Depue BE, Sabbineni A, Bryan AD, Hutchison KE (2015): Daily Marijuana Use Is Not Associated with Brain Morphometric Measures in Adolescents or Adults. The Journal of Neuroscience 35:1505-1512. doi: 10.1523/JNEUROSCI.2946-14.2015 PMID: 25632127
21. Gilman JM, Kuster JK, Lee S, Lee MJ, Kim BW, Makris N, et al (2014): Cannabis Use Is Quantitatively Associated with Nucleus Accumbens and Amygdala Abnormalities in Young Adult Recreational Users. The Journal of Neuroscience 34:5529-5538. doi: 10.1523/JNEUROSCI.4745-13.2014 PMID: 24741043
22. Rocchetti M, Crescini A, Borgwardt S, Caverzasi E, Politi P, Atakan Z, et al (2013): Is cannabis neurotoxic for the healthy brain? A meta-analytical review of structural brain alterations in non-psychotic users. Psychiatry Clin Neurosci 67:483-492. doi: 10.1111/pcn.12085 PMID: 24118193
23. Schoenbaum G, Shaham Y (2008): The Role of Orbitofrontal Cortex in Drug Addiction: A Review of Preclinical Studies. Biol Psychiatry 63:256-262. PMID: 17719014
24. Koob GF, Volkow ND (2009): Neurocircuitry of Addiction. Neuropsychopharmacology 35:217-238.
25. Naqvi NH, Bechara A (2009): The hidden island of addiction: the insula. Trends Neurosci 32:56-67. doi: 10.1016/j.tins.2008.09.009 PMID: 18986715
26. Cousijn J, Vingerhoets WAM, Koenders L, de Haan L, van den Brink W, Wiers RW, et al (2014): Relationship between working-memory network function and substance use: a 3-year longitudinal fMRI study in heavy cannabis users and controls. Addict Biol 19:282-293. doi: 10.1111/adb.12111 PMID: 24589297
27. Roese NJ, Jamieson DW (1993): Twenty Years of Bogus Pipeline Research: A Critical Review and Meta-Analysis. Psychol Bull 114:363-375.
28. Adamson SJ, Sellman JD (2003): A prototype screening instrument for cannabis use disorder: the Cannabis Use Disorders Identification Test (CUDIT) in an alcohol-dependent clinical sample. Drug Alcohol Rev 22:309-315. PMID: 15385225
29. Fagerstrom K, Schneider N (1989): Measuring nicotine dependence: A review of the Fagerstrom Tolerance Questionnaire. J Behav Med 12:159-182. PMID: 2668531
30. Babor TF, Higgins-Biddle JC, Saunders JB, Monteiro MG (2001): Audit. The Alcohol Use Disorders Identification Test (AUDIT): Guidelines for use in primary care.
31. Schmand B, Bakker D, Saan R, Louman J (1991): The Dutch Reading Test for Adults: a measure of premorbid intelligence level. Tijdschr Gerontol Geriatr 22:15-19. PMID: 1877068
32. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al (1998): The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. The Journal of clinical psychiatry JID-7801243 59:22-33.
33. Ashburner J (2007): A fast diffeomorphic image registration algorithm. Neuroimage 38:95-113. PMID: 17761438
34. Nielsen FÅ, Hansen LK (2002): Automatic anatomical labeling of Talairach coordinates and generation of volumes of interest via the BrainMap database.
35. Osborne JW (2010): Improving your data transformations: applying the Box-Cox transformation. Practical Assessment, Research & Evaluation 15:12.
36. Worsley KJ, Marrett S, Neelin P, Vandal AC, Friston KJ, Evans AC (1996): A unified statistical approach for determining significant signals in images of cerebral activation. Hum Brain Mapp 4:58-73. doi: 10.1002/(SICI)1097-0193(1996)4:1〈58::AID-HBM4〉3.0.CO;2-O PMID: 20408186
37. Wierenga L, Langen M, Ambrosino S, van Dijk S, Oranje B, Durston S (2014): Typical development of basal ganglia, hippocampus, amygdala and cerebellum from age 7 to 24. Neuroimage 96:67-72. doi: 10.1016/j.neuroimage.2014.03.072 PMID: 24705201
38. Batalla A, Bhattacharyya S, Yücel M, Fusar-Poli P, Crippa JA, Nogue S, et al (2013): Structural and Functional Imaging Studies in Chronic Cannabis Users: A Systematic Review of Adolescent and Adult Findings. PLoS ONE 8:e55821. doi: 10.1371/journal.pone.0055821 PMID: 23390554
39. Ashtari M, Avants B, Cyckowski L, Cervellione KL, Roofeh D, Cook P, et al (2011): Medial temporal structures and memory functions in adolescents with heavy cannabis use. J Psychiatr Res 45:1055-1066. doi: 10.1016/j.jpsychires.2011.01.004 PMID: 21296361
40. Battistella G, Fornari E, Annoni JM, Chtioui H, Dao K, Fabritius M, et al (2014): Long-Term Effects of Cannabis on Brain Structure. Neuropsychopharmacology.
41. Ramikie TS, Nyilas R, Bluett RJ, Gamble-George JC, Hartley ND, Mackie K, et al (2014): Multiple Mechanistically Distinct Modes of Endocannabinoid Mobilization at Central Amygdala Glutamatergic Synapses. Neuron 81:1111-1125. doi: 10.1016/j.neuron.2014.01.012 PMID: 24607231
42. Katona I, Rancz EA, Acsády L, Ledent C, Mackie K, Hájos N, et al (2001): Distribution of CB1 Cannabinoid Receptors in the Amygdala and their Role in the Control of GABAergic Transmission. The Journal of Neuroscience 21:9506-9518. PMID: 11717385
43. Herkenham M, Lynn AB, Little MD, Johnson MR, Melvin LS, de Costa BR, et al (1990): Cannabinoid receptor localization in brain. Proceedings of the National Academy of Sciences 87:1932-1936.
44. Cheetham A, Allen NB, Whittle S, Simmons JG, Yücel M, Lubman DI (2012): Orbitofrontal Volumes in Early Adolescence Predict Initiation of Cannabis Use: A 4-Year Longitudinal and Prospective Study. Biol Psychiatry 71:684-692. doi: 10.1016/j.biopsych.2011.10.029 PMID: 22129756
45. Benegal V, Antony G, Venkatasubramanian G, Jayakumar PN (2007): Gray matter volume abnormalities and externalizing symptoms in subjects at high risk for alcohol dependence. Addict Biol 12:122-132. PMID: 17407506
46. Sjoerds Z, Van Tol M, van dB, Van dW, Van Buchem MA, Aleman A, et al (2013): Family history of alcohol dependence and gray matter abnormalities in non-alcoholic adults. World J Biol Psychiatry 14:565-573. doi: 10.3109/15622975.2011.640942 PMID: 22283466
47. Filbey FM, Schacht JP, Myers US, Chavez RS, Hutchison KE (2009): Marijuana craving in the brain. Proceedings of the National Academy of Sciences 106:13016-13021.
48. Volkow ND, Fowler JS, Wang G (2003): The addicted human brain: insights from imaging studies. J Clin Invest 111:1444-1451. PMID: 12750391
49. Churchwell JC, Lopez-Larson M, Yurgelun-Todd D (2010): Altered frontal cortical volume and decision making in adolescent cannabis users. Frontiers in Psychology 1:.
50. Ashtari M, Cervellione K, Cottone J, Ardekani BA, Kumra S (2009): Diffusion abnormalities in adolescents and young adults with a history of heavy cannabis use. J Psychiatr Res 43:189-204. doi: 10.1016/j.jpsychires.2008.12.002 PMID: 19111160
51. Jacobus J, Tapert S (2014): Effects of Cannabis on the Adolescent Brain. Current Pharmacological Design 20:1-8.